BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• FDA

  Novo Nordisk A/S’s Novoeight Wins FDA Approval for Hemophilia A

  October 16, 2013

   · 

  1 min read
• GlaxoSmithKline Chief Calls for £1 Billion University Fund to Back Innovation

  October 16, 2013

   · 

  1 min read
• Drug Development

  Gilead Sciences, Inc.'s Single Tablet HIV Regimen Stribild® Demonstrates Durable Viral Suppression Through Three Years of Therapy

  October 16, 2013

   · 

  1 min read
• Deals

  Tuberculosis Diagnostics Firm Oxford Immunotec Limited Files for $86 Million IPO

  October 16, 2013

   · 

  1 min read
• Business

  Zydus Cadila and Pieris Sign Broad Co-Development Alliance for Novel Anticalin® Therapeutics

  October 16, 2013

   · 

  4 min read
• Business

  Luminex CorporationThird Quarter Earnings Release Scheduled for November 4, 2013

  October 16, 2013

   · 

  4 min read
• Pharm Country

  Misonix Incorporated Showcases Ultrasonic BoneScalpel™ at the Annual Meeting of the North American Spine Society

  October 16, 2013

   · 

  5 min read
• Business

  Cubist Pharmaceuticals, Inc. to Announce Third Quarter 2013 Financial Results on Tuesday, October 22, 2013

  October 16, 2013

   · 

  1 min read
• Business

  Exelixis, Inc. Announces October 30th Webcast of Third Quarter 2013 Financial Results Conference Call

  October 16, 2013

   · 

  1 min read
• Business

  e-Therapeutics plc’ Interim Results for the Six Months Ended 31 July 2013

  October 16, 2013

   · 

  1 min read